Patents by Inventor Armend Gazmeno HÅTI

Armend Gazmeno HÅTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF POLYMER-BASED MICROCARRIERS IN THE PRODUCTION OF TISSUE SCAFFOLDS WITH COMPLEX GEOMETRY
    Publication number: 20250025606
    Abstract: A method of manufacturing a tissue scaffold includes the following steps: a) providing a first group of cells and biocompatible hydrogel beads; b) bringing the first group of cells together with the biocompatible hydrogel beads to obtain a first cell-bead mixture; c) culturing the first cell-bead mixture to produce extracellular matrix thereby obtaining a first tissue scaffold; and d) optionally, subjecting the first tissue scaffold to mechanical conditioning thereby obtaining a mechanically conditioned first tissue scaffold. The first group of cells are anchorage dependent cells that can produce and secrete extracellular matrix. The biocompatible hydrogel beads support attachment of the first group of cells.
    Type: Application
    Filed: March 29, 2023
    Publication date: January 23, 2025
    Applicant: NORDOVO BIOSCIENCES AS
    Inventors: Manuel Schweikle, Mia Hauge Rambøl, Armend Gazmeno Håti
  • Methods of forming ionically cross-linked gels
    Patent number: 11767402
    Abstract: The present invention relates to the formation of gels. In particular, the present invention is directed to a method of forming a cross-linked polymer hydrogel using competitive ligand exchange.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: September 26, 2023
    Assignee: Nordovo Biosciences AS
    Inventors: David Charles Bassett, Armend Gazmeno Håti
  • PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY
    Publication number: 20230038627
    Abstract: The present invention relates to pharmaceutical formulations of phospholipids, and in particular pharmaceutical formulations which are administered intravascularly such as intravenously. In particular, the present invention provides pharmaceutical compositions for intravascular administration comprising phosphatidylcholine derived compounds carrying an omega-3 fatty acid for use in prophylaxis or therapy.
    Type: Application
    Filed: June 21, 2020
    Publication date: February 9, 2023
    Inventors: Lotte SKOLEM, Finn MYHREN, Nils HOEM, Petter-Arnt HALS, Andreas BERG STORSVE, Armend Gazmeno HÅTI
  • METHODS OF FORMING IONICALLY CROSS-LINKED GELS
    Publication number: 20210317274
    Abstract: The present invention relates to the formation of gels. In particular, the present invention is directed to a method of forming a cross-linked polymer hydrogel using competitive ligand exchange.
    Type: Application
    Filed: March 26, 2021
    Publication date: October 14, 2021
    Applicant: Nordovo Biosciences AS
    Inventors: David Charles BASSETT, Armend Gazmeno HÅTI
  • Methods of forming ionically cross-linked gels
    Patent number: 10988583
    Abstract: The present invention relates to the formation of gels. In particular, the present invention is directed to a method of forming a cross-linked polymer hydrogel using competitive ligand exchange.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: April 27, 2021
    Assignee: Nordovo Biosciences AS
    Inventors: David Charles Bassett, Armend Gazmeno Håti
  • METHODS OF FORMING IONICALLY CROSS-LINKED GELS
    Publication number: 20190284349
    Abstract: The present invention relates to the formation of gels. In particular, the present invention is directed to a method of forming a cross-linked polymer hydrogel using competitive ligand exchange.
    Type: Application
    Filed: March 9, 2017
    Publication date: September 19, 2019
    Applicant: Nordovo Biosciences AS
    Inventors: David Charles BASSETT, Armend Gazmeno HÅTI